​
​

Hims & Hers Health (HIMS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HIMS Stock Forecast

Hims & Hers Health stock forecast is as follows: an average price target of $21.60 (represents a -19.07% downside from HIMS’s last price of $26.69) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.

HIMS Price Target

The average price target for Hims & Hers Health (HIMS) is $21.60 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $8.00. This represents a potential -19.07% downside from HIMS's last price of $26.69.

HIMS Analyst Ratings

Buy

According to 16 Wall Street analysts, Hims & Hers Health's rating consensus is 'Buy'. The analyst rating breakdown for HIMS stock is 1 'Strong Buy' (6.25%), 10 'Buy' (62.50%), 5 'Hold' (31.25%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Hims & Hers Health Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Korinne WolfmeyerPiper Sandler$21.00$20.641.74%-21.32%
Nov 05, 2024Ryan MacDonaldNeedham$28.00$20.9633.59%4.91%
Oct 29, 2024Michael ChernyLeerink Partners$26.00$23.0812.65%-2.59%
Oct 21, 2024Michael ChernyBank of America Securities$25.00$22.1512.87%-6.33%
Oct 14, 2024Michael ChernyBank of America Securities$23.00$19.8216.02%-13.83%
Oct 14, 2024Jailendra SinghTruist Financial$23.00$19.8216.02%-13.83%
Sep 13, 2024Allen LutzBank of America Securities$20.00$15.8226.42%-25.07%
Aug 27, 2024Daniel GrosslightCitigroup$20.00$14.9334.00%-25.07%
Aug 07, 2024Glen SantangeloJefferies$18.00$16.0412.22%-32.56%
Aug 06, 2024George HillDeutsche Bank$23.00$16.8836.26%-13.83%
Row per page
Go to

The latest Hims & Hers Health stock forecast, released on Nov 05, 2024 by Korinne Wolfmeyer from Piper Sandler, set a price target of $21.00, which represents a 1.74% increase from the stock price at the time of the forecast ($20.64), and a -21.32% decrease from HIMS last price ($26.69).

Hims & Hers Health Price Target by Period

1M3M12M
# Anlaysts6817
Avg Price Target$24.33$23.25$20.12
Last Closing Price$26.69$26.69$26.69
Upside/Downside-8.84%-12.89%-24.62%

In the current month, the average price target of Hims & Hers Health stock is $24.33, according to 6 Wall Street analysts offering twelve months forecast. The average price target represents a -8.84% decrease as opposed to Hims & Hers Health's last price of $26.69. This month's average price target is up 4.65% compared to last quarter, and up 20.92% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 05, 2024NeedhamBuyBuyHold
Oct 29, 2024Leerink PartnersMarket PerformMarket PerformHold
Oct 21, 2024Piper SandlerBuyBuyHold
Oct 21, 2024NeedhamUnderperformUnderperformHold
Oct 14, 2024Bank of America SecuritiesBuyBuyHold
Oct 03, 2024CitigroupNeutralNeutralHold
Sep 13, 2024Sandler O'NeillBuyBuyHold
Sep 13, 2024Sandler O'NeilUnderperformUnderperformHold
Aug 27, 2024CitigroupNeutralNeutralHold
Aug 22, 2024Needham-BuyInitialise
Row per page
Go to

Hims & Hers Health's last stock rating was published by Needham on Nov 05, 2024. The company gave HIMS a "Buy" rating, the same as its previous rate.

Hims & Hers Health Financial Forecast

Hims & Hers Health Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Revenue------------$246.62M$226.70M$207.91M$190.77M$167.20M$144.84M$113.56M$101.31M$84.70M$74.17M$60.69M$52.31M$41.47M
Avg Forecast$541.61M$527.34M$521.97M$513.71M$529.87M$509.03M$514.98M$492.56M$464.77M$382.20M$304.66M$270.37M$246.47M$220.08M$204.95M$179.08M$161.17M$130.32M$103.89M$91.23M$76.79M$70.53M$56.49M$48.71M$37.00M
High Forecast$563.22M$548.39M$542.80M$534.21M$551.02M$529.34M$535.53M$514.62M$469.83M$384.05M$305.76M$270.37M$247.45M$220.08M$213.13M$186.22M$167.61M$130.32M$103.89M$91.23M$76.79M$70.53M$56.49M$48.71M$37.00M
Low Forecast$499.91M$486.75M$481.79M$474.17M$489.08M$469.84M$475.33M$453.96M$461.73M$380.34M$303.56M$270.37M$245.14M$220.08M$189.18M$165.29M$148.77M$130.32M$103.89M$91.23M$76.79M$70.53M$56.49M$48.71M$37.00M
# Analysts3333444694347563222234566
Surprise %------------1.00%1.03%1.01%1.07%1.04%1.11%1.09%1.11%1.10%1.05%1.07%1.07%1.12%

Hims & Hers Health's average Quarter revenue forecast for Mar 24 based on 4 analysts is $270.37M, with a low forecast of $270.37M, and a high forecast of $270.37M. HIMS's average Quarter revenue forecast represents a 9.63% increase compared to the company's last Quarter revenue of $246.62M (Dec 23).

Hims & Hers Health EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
# Analysts3333444694347563222234566
EBITDA------------$-400.00K$-8.55M$-9.24M$-9.15M$-11.61M$-18.53M$-18.49M$-15.62M$-29.62M$-17.57M$-8.61M$-50.92M$-4.84M
Avg Forecast$-166.77M$-162.38M$-160.73M$-158.18M$-163.16M$-156.74M$-158.57M$-151.67M$-143.11M$-117.69M$-93.81M$-81.48M$-75.89M$-67.77M$-63.11M$-64.41M$-27.84M$-40.13M$-17.85M$-28.09M$-23.65M$-21.72M$-17.39M$-50.92M$-11.39M
High Forecast$-153.93M$-149.88M$-148.35M$-146.01M$-150.60M$-144.67M$-146.37M$-139.78M$-142.18M$-117.11M$-93.47M$-65.19M$-75.49M$-67.77M$-58.25M$-51.53M$-22.27M$-40.13M$-14.28M$-28.09M$-23.65M$-21.72M$-17.39M$-40.74M$-11.39M
Low Forecast$-173.43M$-168.86M$-167.14M$-164.50M$-169.67M$-163.00M$-164.90M$-158.46M$-144.67M$-118.26M$-94.15M$-97.78M$-76.19M$-67.77M$-65.63M$-77.30M$-33.40M$-40.13M$-21.42M$-28.09M$-23.65M$-21.72M$-17.39M$-61.10M$-11.39M
Surprise %------------0.01%0.13%0.15%0.14%0.42%0.46%1.04%0.56%1.25%0.81%0.50%1.00%0.42%

undefined analysts predict HIMS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Hims & Hers Health's previous annual EBITDA (undefined) of $NaN.

Hims & Hers Health Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
# Analysts3333444694347563222234566
Net Income------------$3.15M$-7.57M$-7.16M$-10.07M$-10.91M$-18.84M$-19.68M$-16.25M$-31.16M$-15.94M$-9.15M$-51.40M$-5.23M
Avg Forecast$39.63M$42.93M$41.86M$42.26M$54.07M$49.36M$44.66M$38.39M$41.76M$26.14M$10.48M$-82.26M$-5.25M$-8.39M$-11.40M$-65.03M$-29.29M$-23.81M$-19.68M$-19.52M$-20.85M$-18.82M$-19.51M$-51.40M$-37.72M
High Forecast$41.68M$45.16M$44.03M$44.46M$56.87M$51.93M$46.98M$70.88M$66.81M$27.50M$10.78M$-65.81M$-2.62M$-7.55M$-10.26M$-52.02M$-23.43M$-23.81M$-15.74M$-19.52M$-20.85M$-18.82M$-19.51M$-41.12M$-37.72M
Low Forecast$35.66M$38.63M$37.67M$38.03M$48.65M$44.42M$40.19M$23.63M$16.70M$23.53M$10.18M$-98.71M$-10.49M$-8.82M$-11.99M$-78.03M$-35.14M$-23.81M$-23.61M$-19.52M$-20.85M$-18.82M$-19.51M$-61.68M$-37.72M
Surprise %-------------0.60%0.90%0.63%0.15%0.37%0.79%1.00%0.83%1.49%0.85%0.47%1.00%0.14%

Hims & Hers Health's average Quarter net income forecast for Mar 24 is $-82.26M, with a range of $-98.71M to $-65.81M. HIMS's average Quarter net income forecast represents a -2713.85% decrease compared to the company's last Quarter net income of $3.15M (Dec 23).

Hims & Hers Health SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
# Analysts3333444694347563222234566
SG&A------------$158.21M$151.98M$138.36M$127.76M$113.11M$126.46M$107.37M$91.67M$83.66M$82.53M$64.68M$88.66M$36.52M
Avg Forecast$542.21M$527.93M$522.55M$514.28M$530.46M$509.59M$515.55M$493.10M$465.29M$382.62M$305.00M$141.87M$246.74M$220.32M$205.18M$112.15M$78.63M$130.47M$46.88M$91.34M$76.88M$70.61M$56.55M$48.77M$37.04M
High Forecast$563.84M$549.00M$543.40M$534.80M$551.63M$529.93M$536.12M$515.19M$470.35M$384.48M$306.10M$170.24M$247.72M$220.32M$213.37M$134.58M$94.36M$130.47M$56.25M$91.34M$76.88M$70.61M$56.55M$48.77M$37.04M
Low Forecast$500.47M$487.29M$482.32M$474.69M$489.62M$470.36M$475.86M$454.46M$462.24M$380.76M$303.90M$113.50M$245.42M$220.32M$189.38M$89.72M$62.91M$130.47M$37.50M$91.34M$76.88M$70.61M$56.55M$48.77M$37.04M
Surprise %------------0.64%0.69%0.67%1.14%1.44%0.97%2.29%1.00%1.09%1.17%1.14%1.82%0.99%

Hims & Hers Health's average Quarter SG&A projection for Mar 24 is $141.87M, based on 4 Wall Street analysts, with a range of $113.50M to $170.24M. The forecast indicates a -10.33% fall compared to HIMS last annual SG&A of $158.21M (Dec 23).

Hims & Hers Health EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
# Analysts3333444694347563222234566
EPS-------------$-0.04$-0.03$-0.05$-0.05$-0.09$-0.10$-0.08$-0.15$-0.08$-0.05$-0.34$-0.07
Avg Forecast$0.17$0.18$0.18$0.18$0.23$0.21$0.19$0.16$0.18$0.11$0.04$0.01$-0.02$-0.04$-0.05$-0.02$-0.06$-0.10$-0.08$-0.08$-0.09$-0.08$-0.08$-0.11$-0.16
High Forecast$0.18$0.19$0.19$0.19$0.24$0.22$0.20$0.30$0.28$0.12$0.05$0.01$-0.01$-0.03$-0.04$-0.02$-0.05$-0.10$-0.08$-0.08$-0.09$-0.08$-0.08$-0.11$-0.16
Low Forecast$0.15$0.16$0.16$0.16$0.21$0.19$0.17$0.10$0.07$0.10$0.04$0.01$-0.04$-0.04$-0.05$-0.02$-0.06$-0.10$-0.08$-0.08$-0.09$-0.08$-0.08$-0.11$-0.16
Surprise %-------------1.01%0.71%2.36%0.90%0.91%1.19%0.96%1.69%1.00%0.60%3.14%0.44%

According to undefined Wall Street analysts, Hims & Hers Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HIMS previous annual EPS of $NaN (undefined).

Hims & Hers Health Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
GROVGrove Collaborative$1.52$150.009768.42%Buy
ELEstée Lauder Companies$62.74$168.50168.57%Hold
NWLNewell Brands$9.18$16.1475.82%Hold
COTYCoty$7.47$12.3565.33%Buy
IPARInter Parfums$126.00$163.5029.76%Buy
ELFe.l.f. Beauty$131.33$143.189.02%Buy
CLColgate-Palmolive Company$91.50$93.652.35%Buy
KVUEKenvue$23.65$23.00-2.75%Hold
PGProcter & Gamble Company$165.84$160.09-3.47%Buy
HNSTHonest Company$4.80$4.25-11.46%Buy
HIMSHims & Hers Health$26.69$21.60-19.07%Buy

HIMS Forecast FAQ

Is Hims & Hers Health a good buy?

Yes, according to 16 Wall Street analysts, Hims & Hers Health (HIMS) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 10 'Buy' recommendations, accounting for 68.75% of HIMS's total ratings.

What is HIMS's price target?

Hims & Hers Health (HIMS) average price target is $21.6 with a range of $8 to $28, implying a -19.07% from its last price of $26.69. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Hims & Hers Health stock go up soon?

According to Wall Street analysts' prediction for HIMS stock, the company can go down by -19.07% (from the last price of $26.69 to the average price target of $21.6), up by 4.91% based on the highest stock price target, and down by -70.03% based on the lowest stock price target.

Can Hims & Hers Health stock reach $40?

HIMS's average twelve months analyst stock price target of $21.6 does not support the claim that Hims & Hers Health can reach $40 in the near future.

What is Hims & Hers Health's current price target trend?

6 Wall Street analysts forecast a $24.33 price target for Hims & Hers Health (HIMS) this month, down -8.84% from its last price of $26.69. Compared to the last 3 and 12 months, the average price target decreased by -12.89% and decreased by -24.62%, respectively.

What are Hims & Hers Health's analysts' financial forecasts?

Hims & Hers Health's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.05B (high $2.13B, low $1.89B), average EBITDA is $-630M (high $-581M, low $-656M), average net income is $186.49M (high $226.66M, low $156.9M), average SG&A $2.05B (high $2.13B, low $1.89B), and average EPS is $0.793 (high $0.964, low $0.667). HIMS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.1B (high $2.19B, low $1.94B), average EBITDA is $-648M (high $-598M, low $-674M), average net income is $166.68M (high $175.33M, low $150M), average SG&A $2.11B (high $2.19B, low $1.94B), and average EPS is $0.709 (high $0.746, low $0.638).

Did the HIMS's actual financial results beat the analysts' financial forecasts?

Based on Hims & Hers Health's last annual report (Dec 2023), the company's revenue was $872M, beating the average analysts forecast of $850.58M by 2.52%. Apple's EBITDA was $-29.453M, missing the average prediction of $-271M by -89.14%. The company's net income was $-23.546M, missing the average estimation of $-90.056M by -73.85%. Apple's SG&A was $576.32M, missing the average forecast of $784.39M by -26.53%. Lastly, the company's EPS was $-0.0001, missing the average prediction of $-0.127 by -99.92%. In terms of the last quarterly report (Dec 2023), Hims & Hers Health's revenue was $246.62M, beating the average analysts' forecast of $246.47M by 0.06%. The company's EBITDA was $-400K, missing the average prediction of $-75.892M by -99.47%. Hims & Hers Health's net income was $3.15M, missing the average estimation of $-5.246M by -159.99%. The company's SG&A was $158.21M, missing the average forecast of $246.74M by -35.88%. Lastly, the company's EPS was $0, missing the average prediction of $-0.0223 by -100.00%